CFOR

PINK CapForce Inc.
Oct 12, 2026 · 11:03 PM ET EOD Market Closed

$3.99 ↑ +0.03 (+0.71%) Trading Up from the previous close of $3.97, $0.01 below the day’s high of $4.00

YTD change
+1121.41%
vs 20-day SMA
-2.29%
vs 200-day SMA
N/A

Price ranges

Previous day
$3.85 $4.00
open $4.00 close $3.99
-$0.01 (-0.15%)
Today
$3.85 $4.00
open $4.00 now $3.99
-$0.01 (-0.15%)
Past week
$3.90 $4.05
from $3.90 now $3.99
+$0.09 (+2.41%)
Past month
$3.05 $5.15
from $4.00 now $3.99
-$0.01 (-0.15%)
This year
$0.00 $25.00
from $0.33 now $3.99
+$3.67 (+1121.41%)

Price & Performance

-19.01 (-82.63%) / 6M

$-1.8395$7.05$15.95$24.84Apr 16Aug 13Oct 9

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 88.3% away from all-time highs of $34.00
  • CFOR is up 1121% since the beginning of the year
  • CFOR is up 1121% over the past 12 months
  • CFOR is down 0% over the past 1 month
  • 0% of all CFOR investors are betting against CFOR

CFOR reads n/a: the 12-month move is -83.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $3.3841
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio 0.76
Enterprise value $51.3M
Beta -13,028.40

Balance sheet & scale

Income$62.3K
Revenue$76.2M
Cash$143.8K
Debt$2.0K
Income / Debt 31.79×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Health Care and Social Assistance
Sub Sector Ambulatory Health Care Services
Market cap $49.5M

CapForce, Inc. is a precision medicine company, which engages in the power of molecular diagnostics and informatics to help combat infectious disease. It focuses on the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Clarksburg, MD.

Competitor comparison

TickerCompany PriceChange
DGX Quest Diagnostics Incorporated $232.63 +0.72%
LH Labcorp Holdings Inc. $315.52 +1.08%
SKHHY Sonic Healthcare Limited Sponsored ADR $12.90 -0.88%
GRAL GRAIL Inc $137.37 -2.28%
BLLN BillionToOne, Inc. Class A $93.07 -5.12%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.